Ally Financial’s Boston Scientific BSX Stock Holding History

Ally Financial’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.88M	Hold	66,000	–	–	0.4%	66
2026 Q2	$2.82M	Hold	66,000	–	–	0.36%	70
2026 Q1	$4.14M	Buy	66,000 +55,000	+500%	+$4.4M	0.52%	46
2025 Q4	$1.05M	Buy	+11,000	New	+$1.08M	0.13%	100
2024 Q1	–	Sell	-29,000	Closed	-$1.68M	–	110
2023 Q4	$1.68M	Hold	29,000	–	–	0.22%	77
2023 Q3	$1.53M	Buy	+29,000	New	+$1.52M	0.23%	82
2023 Q2	–	Sell	-13,000	Closed	-$650K	–	99
2023 Q1	$650K	Hold	13,000	–	–	0.1%	87
2022 Q4	$602K	Hold	13,000	–	–	0.09%	99
2022 Q3	$503K	Hold	13,000	–	–	0.08%	108
2022 Q2	$485K	Buy	+13,000	New	+$529K	0.07%	113

Other funds holding BSX

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Ally Financial's BSX Position: Q3 2026 in Review

Ally Financial held its Boston Scientific (BSX) position steady in Q3 2026 at 66,000 shares worth $2.88M. The position accounts for 0.4% of the portfolio, ranked #66.

Ally Financial first reported a position in BSX in Q2 2022 and has held it in 10 quarters since. The position peaked at $4.14M in Q1 2026. 1,095 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Ally Financial held 66,000 shares of Boston Scientific worth $2.88M as of Q3 2026.
Ally Financial left its Boston Scientific share count unchanged in Q3 2026.
Boston Scientific made up 0.4% of Ally Financial's portfolio in Q3 2026, its #66 holding.
Ally Financial first reported a position in Boston Scientific in Q2 2022 and has held it in 10 quarters since.
Ally Financial's Boston Scientific position peaked at $4.14M in Q1 2026.
1,095 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Ally Financial's 13F filing for Q3 2026, filed 12 Nov 2026.